1. Home
  2. AVIR

AVIR

Atea Pharmaceuticals Inc.

Logo Atea Pharmaceuticals Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Founded: N/A Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 316.5M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 437.3K
Analyst Decision: Sell Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.63 EPS Growth: N/A
52 Week Low/High: $2.77 - $5.19 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: